Article info

Original research
Impact of cascade screening for catecholaminergic polymorphic ventricular tachycardia type 1

Authors

  1. Correspondence to Dr Takeshi Aiba, Department of Cardiovascular Medicine, National Cerebral and Cardiovascular Center, Suita 564-8565, Japan; aiba{at}ncvc.go.jp
View Full Text

Citation

Shimamoto K, Ohno S, Kato K, et al
Impact of cascade screening for catecholaminergic polymorphic ventricular tachycardia type 1

Publication history

  • Received August 23, 2021
  • Accepted December 30, 2021
  • First published February 8, 2022.
Online issue publication 
May 12, 2022

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.